Overview

A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine

Status:
Unknown status
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
A pilot trial of triheptanoin, a natural compound able to promote anaplerotic mitochondrial metabolism, for the preventative treatment of migraine.
Phase:
Early Phase 1
Details
Lead Sponsor:
University Hospital of Liege
University of Liege